FDA reverses course and will review Moderna’s mRNA flu shot, company says
By Deidre McPhillips, NCS (NCS) — The US Food and Drug Administration has reversed course and will review a brand new mRNA flu vaccine from Moderna, the pharmaceutical company stated…